• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Core One Labs Inc., Signs a Definitive Agreement to Acquire Cultivation Facility in Canada

Share:

November 11, 2019

Core One Labs Inc. Logo

Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) (“COOL” or the “Company”) announces it has signed a Definitive Agreement to acquire Rainy Daze Cannabis Corp., a British Columbia corporation. The corporation’s assets include a long term lease for a facility currently under construction and scheduled to be completed in the 2nd Qtr of 2020. The facility comprises 2,210 square feet of canopy space and 3,500 square feet of operational purpose built building. Also included are 15 top proprietary genetics with the necessary farming protocols and SOPs to ensure both maximum yield and compliance.

The corporation being acquired was organized by Chadwick Clelland, currently CEO of a fully licensed Canadian LP with Cultivation and Medical Sales licenses. The facility under construction has a license application in process.

The facility will be operated by experienced staff with LP credentials. Seed to sale software and distribution agreement will guarantee shelf space with a group of over 12 licensed locations in western Canada. This is an opportunity to independently brand all of Core One Labs’ products in the Canadian market. Extraction capabilities on site will permit this corporation to enter the edibles and extracts markets.

With this acquisition, Core One Labs will be positioned to build a foundation in Canada for national distribution and international export of all COOL products, including CannaStripsTM. The CEO of Core One Labs Inc., Brad Eckenweiler, commented, “The estimated revenue numbers for this facility, when completed, suggest an ROI of over fifty percent annually. The guaranteed flower purchase with a growing number of licensed dispensaries is very attractive to the COOL business model for Canada. The location of the facility in British Columbia where COOL currently has offices is an additional benefit.” The Company will continue to update the market on the progress of this project as we proceed to its completion.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: PR Newswire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 DaysWound Healing and Limb Salvaging Technology Adds to Company’s Asset Portfolio Focused on Unmet Medical NeedsH-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 DaysWound Healing and Limb Salvaging Technology Adds to Company’s Asset Portfolio Focused on Unmet Medical Needs
  • Abbott Completes Acquisition of Bigfoot BiomedicalAbbott Completes Acquisition of Bigfoot Biomedical
  • Lark Health Rolls Out Behavioral Health Coaching Targeted at Patients at Risk for Chronic ConditionsLark Health Rolls Out Behavioral Health Coaching Targeted at Patients at Risk for Chronic Conditions
  • Cancer and Neuroscience Led 2023 VC, M&A Investment in BiopharmaCancer and Neuroscience Led 2023 VC, M&A Investment in Biopharma
  • Fitbit Launches Large-scale Consumer Health Study to Detect A-Fib Via Heart Rate Sensors, AlgorithmFitbit Launches Large-scale Consumer Health Study to Detect A-Fib Via Heart Rate Sensors, Algorithm
  • Edwards Lifesciences Completes Acquisition of CASMEDEdwards Lifesciences Completes Acquisition of CASMED
  • Provider Credentialing: A Problematic Process Driving Costs and DelaysProvider Credentialing: A Problematic Process Driving Costs and Delays
  • Haemonetics Corporation Completes Acquisition of OpSens Inc.Haemonetics Corporation Completes Acquisition of OpSens Inc.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications